TALS

Talaris Therapeutics Inc

A biotechnology company that developed cell therapies to help organ transplant recipients accept a donated organ without lifelong immunosuppressive drugs. Founded in 2002 as Regenerex by transplant surgeon Suzanne Ildstad, it built its approach on her discovery of "facilitating cells." The name comes from "talaria," the winged sandals of the Greek messenger god Hermes, chosen to reflect how the therapy protects and delivers immune cells to safety. In 2023 it merged with Tourmaline Bio, which now runs the combined company.

No Schedule 13D or 13G filings recorded.